在加拿大获得瘤药物的机会:共识论坛提出改善建议
Sandeep R Sehdev1, Nigel S B Rawson2, Olexiy I Aseyev3
1Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
加拿大癌症患者因漫长的批准和谈判过程而面临延迟获得新瘤药物的困难. 临床医生建议改善政府绩效标准,以更快地获得拯救生命的癌症疗法.
科学领域:
- 在瘤学瘤学.
- 卫生政策 卫生政策
- 卫生经济学 卫生经济学
背景情况:
- 在加拿大,获得新型瘤药物的机会受到连续的监管,医疗技术评估 (HTA) 和价格谈判检查站的阻碍.
- 这些系统性延迟阻碍了患者及时获得最佳癌症疗法,并让医疗保健提供者感到丧.
- 目前的流程阻止了指导方针支持的现代治疗的交付.
研究的目的:
- 为政府绩效标准制定共识建议,以改善患者获得瘤药物的机会.
- 在加拿大解决药物批准和资金的及时性和流程.
- 增强瘤学家处方与国际标准一致的最佳疗法的能力.
主要方法:
- 采用了经过修改的Delphi方法,涉及18名加拿大瘤临床医生 (医学,护理,药房).
- 在五个主要主题的30个问题上寻求共识:问责制,差异,终点,及时性和成本效益.
- 该研究的重点是确定合理的政府药物获取绩效标准.
主要成果:
- 达成共识,需要在监管和HTA过程中提高透明度.
- 临床医生对药物批准和资金的延迟表示严重丧.
- 有一个明确的需求提高及时性在获取拯救生命的癌症疗法,与其他国家相比.
结论:
- 加拿大医疗保健系统迫切需要改进,以加快患者获得新的瘤药物.
- 加强政府绩效标准和提高透明度对于及时获得最佳癌症护理至关重要.
- 与比较国家对准准入口对于改善患者存活率至关重要.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Treatment Resistant Cancers
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Cancer Survival Analysis
